OS Therapies Inc financial data

Symbol
OSTX on NYSE
Location
15825 Shady Grove Road, Suite 135, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15.9 %
Debt-to-equity -107 %
Return On Equity 60.7 % +68.6%
Return On Assets -359 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.7M shares +80.8%
Common Stock, Shares, Outstanding 20.9M shares +291%
Entity Public Float 0 USD
Common Stock, Value, Issued 20.9K USD +291%
Weighted Average Number of Shares Outstanding, Basic 15.9M shares +198%
Weighted Average Number of Shares Outstanding, Diluted 15.9M shares +198%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.84M USD -11.7%
General and Administrative Expense 3.97M USD +253%
Operating Income (Loss) -6.81M USD -56.9%
Nonoperating Income (Expense) -2.07M USD +40%
Net Income (Loss) Attributable to Parent -8.88M USD -14%
Earnings Per Share, Basic -0.18 USD/shares +52.6%
Earnings Per Share, Diluted -0.18 USD/shares +52.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 5.53M USD +600%
Property, Plant and Equipment, Net 5.27K USD -34.5%
Assets 5.54M USD +594%
Accounts Payable, Current 1.66M USD -38.8%
Accrued Liabilities, Current 521K USD +221%
Liabilities, Current 4.63M USD -81.3%
Liabilities 4.73M USD -80.9%
Retained Earnings (Accumulated Deficit) -40.4M USD -36.9%
Stockholders' Equity Attributable to Parent -5.24M USD +78.2%
Liabilities and Equity 5.54M USD +594%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -642K USD -49.9%
Net Cash Provided by (Used in) Financing Activities 703K USD +15.1%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 20.9M shares +291%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.53M USD +14095%
Deferred Tax Assets, Valuation Allowance 8.5M USD +31.3%
Deferred Tax Assets, Gross 8.5M USD +31.3%
Depreciation 695 USD +595%
Deferred Tax Assets, Operating Loss Carryforwards 6.56M USD +36.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 35.1M USD +540%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 829K USD +3.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%